Proteomics takes diabetes marker to America
Perth biotechnology group Proteomics International Laboratories has reached an agreement to exclusively licence its PromarkerD test for diabetes to Sonic Healthcare USA. An estimated 32 million people or 11 percent of the American population live with diabetes, with PromarkerD the only test available that is able to identify their risk of developing diabetic kidney disease.…